<--- Back to Details
First PageDocument Content
Estrogens / Steroids / Endocrine system / Reproduction / Chemistry / Androstenediol / 3-Androstanediol / Androstane / 4-Androstenedione / Androstenedione / Androsterone / Epiandrosterone
Date: 2016-04-06 10:54:29
Estrogens
Steroids
Endocrine system
Reproduction
Chemistry
Androstenediol
3-Androstanediol
Androstane
4-Androstenedione
Androstenedione
Androsterone
Epiandrosterone

WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST

Add to Reading List

Source URL: www.westend69ers.de

Download Document from Source Website

File Size: 244,92 KB

Share Document on Facebook

Similar Documents

Estrogens / Steroids / Endocrine system / Reproduction / Chemistry / Androstenediol / 3-Androstanediol / Androstane / 4-Androstenedione / Androstenedione / Androsterone / Epiandrosterone

WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST

DocID: 1ruc9 - View Document

Estrogens / Steroids / Endocrine system / Reproduction / Chemistry / Androstenediol / 3-Androstanediol / Androstane / 4-Androstenedione / Androstenedione / Androsterone / Epiandrosterone

WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST

DocID: 1mJ5p - View Document

Exemestane / Pfizer / Selective estrogen receptor modulators / Phenols / Tamoxifen / Hormonal therapy / Mastectomy / Estrogen / Androstenedione / Medicine / Pharmacology / Aromatase inhibitors

AROMASIN® (exemestane tablets) NDA[removed]S-006 October 4, 2005 S-006 Approved Labeling EBC Indication

DocID: FQ3l - View Document

Medicine / Androstenedione / 4-Androstenediol / Andrology / Androgen / Tribulus terrestris / Testosterone / 5-Androstenediol / Anabolic steroids / Steroids / Endocrine system

PDF Document

DocID: xUnx - View Document

Adrenal gland disorders / Intersexuality / 17-Hydroxyprogesterone / Progestagens / Steroids / Congenital adrenal hyperplasia / Newborn screening / Androstenedione / Association of Public Health Laboratories / Health / Medicine / Pediatrics

December[removed]INTRODUCTION This report is the quarterly summary of all data reported within the specified data-reporting period for Quarter 4, 2013. The attached tables provide the certification profiles for the distrib

DocID: jL1i - View Document